Abstract:Background: To develop and validate a radiomic signature for the prediction of lymph node metastasis (LNM) in T1 colorectal cancer (CRC) patients by utilizing common, non-invasive, clinical imaging data. With this signature, patients with T1 CRC at a lower-risk of LNM may avoid extensive radical surgical treatments required in high-risk cases.Methods: This retrospective analysis included 559 T1 CRC patients enrolled at three hospitals. Key radiomic features were extracted from CT images and T2w-MR images using a coarse-to-fine feature selection strategy. These features were used to generate three radiomic signatures based on CT, MR and combined (CT&MR) imaging data. The performance of these radiomic signatures were compared within the primary and external validation cohorts. Furthermore, their prediction performance and clinical usefulness were measured and compared with those of a clinical information-based model.Findings: The radiomic signature combining CT and MR images achieved AUCs of 0.872 (95% CI, 0.770-0.974) in the primary cohort and 0.812 (95% CI, 0.709-0.915) in validation cohort 1, which were significantly better than those of other prediction models. More importantly, the signature achieved high negative predictive values (95.5% in the primary cohort and 97.9% in the validation cohort 1). The decision curve analysis demonstrated the clinical usefulness of this signature.Interpretation: The study suggests that the radiomic signature can accurately predict LNM in cases of T1 CRC. Furthermore, combining CT and MR images can achieve better performance. Specifically, the radiomic signature can potentially reduce overtreatment in patients who were misdiagnosed as LNM+.Funding: This work was supported by grants from the National Natural Science Foundation of China (Nos. 81922040, 81920108026, 81871964, 81930053, 81227901, and 81527805), the National Ten Thousand Plan Young Top Talents (for Dr. Yanlei Ma), the Shanghai Young Top Talents (for Dr. Yanlei Ma. No. QNBJ1701), the Shanghai Science and Technology Development Fund (No.19410713300), CSCO-Roche Tumor Research Fund (No. Y-2019Roche-079), the Fudan Outstanding Young Talent Training Plan (No.YJYQ201601), and the Shanghai Pujiang Program (No.17PJD007), the Beijing Natural Science Foundation under Grant No. 7182109, the National Key Research and Development Plan of China under Grant Nos. 2017YFA0205200, the Youth Innovation Promotion Association CAS (grant number 2019136). Declaration of Interest: The authors indicated no potential conflicts of interest.Ethical Approval: The study protocol complied with the Declaration of Helsinki and was approved by the ethics committee of each participating hospital.

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

CT Delta-Radiomics for Identification of Advanced EGFR-Mutated Lung Adenocarcinoma Sensitive to Therapies Targeting EGFR Pathway

KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?

Predicting Kirsten Rat Sarcoma Virus Gene Mutation Status in Patients With Colorectal Cancer by Radiomics Models Based on Multiphasic CT

MRI Radiomics Signature As a Potential Biomarker to Predict Different KRAS Status in Colorectal Cancer Patients and Tumor Cells

MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients

CT-based non-invasive identification of the most common gene mutation status in patients with non-small cell lung cancer

Deep Learning Features Improve the Performance of a Radiomics Signature for Predicting KRAS Status in Patients with Colorectal Cancer

A Novel Radiomic Signature for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer: A Multicenter Study

Non-invasive prediction of microsatellite instability in colorectal cancer by a genetic algorithm–enhanced artificial neural network–based CT radiomics signature

KRAS Status Predicted by Pretreatment MRI Radiomics Was Associated with Lung Metastasis in Locally Advanced Rectal Cancer Patients.

Computed Tomography-Based Radiomic Features Could Potentially Predict Microsatellite Instability Status in Stage II Colorectal Cancer: A Preliminary Study

Novel Radiomics Signature Predicts Lymph Node Metastasis in T1 Colorectal Carcinoma.

Machine Learning-Based Radiomics Signatures for EGFR and KRAS Mutations Prediction in Non-Small-Cell Lung Cancer

Preoperative prediction of early recurrence in patients with BRAF mutant colorectal cancer using a intergrated nomogram

CT-Based Radiomics Signature: A Potential Biomarker for Predicting Postoperative Recurrence Risk in Stage II Colorectal Cancer

CT Radiomics Predict EGFR-T790M Resistance Mutation in Advanced Non-Small Cell Lung Cancer Patients After Progression on First-line EGFR-TKI

Non-invasive CT radiomic biomarkers predict microsatellite stability status in colorectal cancer: a multicenter validation study

Individualized Prediction of Colorectal Cancer Metastasis Using a Radiogenomics Approach

Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis

A multicenter study: predicting KRAS mutation and prognosis in colorectal cancer through a CT-based radiomics nomogram